Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 5,800 shares at $28.43 ($163K) on 2014-01-02, disclosed to the SEC on 2014-01-03.
Scheduled sale ($163k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.96 | 4,630 | $129K | 79.6% |
| 2 | $28.43 | 1,170 | $33K | 20.4% |
| Total | $28.05 avg | 5,800 | $163K | 100% |
| Filing → |
| ENTA | SELL | 2024-12-10 | $41K | — | Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |